{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:51:28Z","timestamp":1790841088333,"version":"4.1.0"},"reference-count":293,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.addr.2021.05.019","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T06:49:49Z","timestamp":1621838989000},"page":"113809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases"],"prefix":"10.1016","volume":"175","author":[{"given":"Elias","family":"Fattal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/wnan.157","article-title":"Nanotherapeutic approaches for the treatment of rheumatoid arthritis","volume":"3","author":"Pham","year":"2011","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2021.05.019_b0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biopha.2016.03.004","article-title":"Utilization of nanoparticle technology in rheumatoid arthritis treatment","volume":"80","author":"Dolati","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1630","article-title":"Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis","volume":"12","author":"Yu","year":"2020","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40259-018-0286-1","article-title":"Oligonucleotide-Based Therapies for Inflammatory Bowel Disease","volume":"32","author":"Bevivino","year":"2018","journal-title":"BioDrugs."},{"key":"10.1016\/j.addr.2021.05.019_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SHK.0b013e318194bcee","article-title":"TARGETED DELIVERY OF siRNA TO CELL DEATH PROTEINS IN SEPSIS","volume":"32","author":"Brahmamdam","year":"2009","journal-title":"Shock."},{"key":"10.1016\/j.addr.2021.05.019_b0040","unstructured":"L. Pradhan-Nabzdyk, C. Huang, F.W. LoGerfo, C.S. Nabzdyk, Current siRNA targets in atherosclerosis and aortic aneurysm, Discov. Med. 17 (2014) 233\u2013246. \/pmc\/articles\/PMC4295203\/ (accessed April 8, 2021)."},{"key":"10.1016\/j.addr.2021.05.019_b0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cbi.2019.05.028","article-title":"Satija, Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases","volume":"308","author":"Mehta","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.addr.2021.05.019_b0055","doi-asserted-by":"crossref","unstructured":"S.Y. Wu, G. Lopez-Berestein, G.A. Calin, A.K. Sood, RNAi Therapies: Drugging the Undruggable, Sci. Transl. Med. 6 (2014) 240ps7 LP-240ps7. http:\/\/doi.org\/10.1126\/scitranslmed.3008362.","DOI":"10.1126\/scitranslmed.3008362"},{"key":"10.1016\/j.addr.2021.05.019_b0060","doi-asserted-by":"crossref","unstructured":"H.E. Moser, P.B. Dervan, Sequence - specific cleavage of double helical DNA by triple helix formation, Science (80-.). 238 (1987) 645\u2013650. doi:10.1126\/science.3118463.","DOI":"10.1126\/science.3118463"},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/nat.2016.0656","article-title":"Molecular Mechanisms of Antisense Oligonucleotides","volume":"27","author":"Crooke","year":"2017","journal-title":"Nucleic Acid Ther."},{"issue":"37","key":"10.1016\/j.addr.2021.05.019_b0070","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1016\/S0040-4039(01)89794-X","article-title":"Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloro-ethylamine and nitrogen mustard residues","volume":"8","author":"Belikova","year":"1967","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.addr.2021.05.019_b0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0080","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1073\/pnas.86.10.3474","article-title":"Characterization of oligonucleotide transport into living cells","volume":"86","author":"Loke","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.addr.2021.05.019_b0085","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","article-title":"2\u2019-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells","volume":"272","author":"Baker","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/jmbi.1999.3277","article-title":"Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation","volume":"294","author":"Dias","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.addr.2021.05.019_b0095","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1073\/pnas.85.14.5011","article-title":"Role of RNase H in hybrid-arrested translation by antisense oligonucleotides","volume":"85","author":"Walder","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2021.05.019_b0100","doi-asserted-by":"crossref","unstructured":"M.F. Neurath, S. Pettersson, K.H. Meyer Zum Buschenfelde, W. Strober, Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-\u03baB abrogates established experimental colitis in mice, Nat. Med. 2 (1996) 998\u20131004. http:\/\/doi.org\/10.1038\/nm0996-998.","DOI":"10.1038\/nm0996-998"},{"issue":"1 INTESTINAL PL","key":"10.1016\/j.addr.2021.05.019_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1749-6632.1998.tb11119.x","article-title":"Cytokine Gene Transcription By NF-kappaB Family Members in Patients with Inflammatory Bowel Disease","volume":"859","author":"Neurath","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.addr.2021.05.019_b0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2249.2000.01183.x","article-title":"Therapeutic effect of intracolonically administered nuclear factor \u03baB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)- induced colitis","volume":"120","author":"Murano","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"15","key":"10.1016\/j.addr.2021.05.019_b0115","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b0120","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2003.08.027","article-title":"A Murine Model of Chronic Inflammation-Induced Intestinal Fibrosis Down-Regulated by Antisense NF-\u03baB","volume":"125","author":"Lawrance","year":"2003","journal-title":"Gastroenterology."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/13543784.2017.1349753","article-title":"Alicaforsen for the treatment of inflammatory bowel disease","volume":"26","author":"Jairath","year":"2017","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1016\/j.addr.2021.05.019_b0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fphar.2019.00314","article-title":"Oligonucleotides\u2014A Novel Promising Therapeutic Option for IBD","volume":"10","author":"Scarozza","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1165\/rcmb.2005-0456OC","article-title":"Anti-Inflammatory Activity of Inhaled IL-4 Receptor-\u03b1 Antisense Oligonucleotide in Mice","volume":"36","author":"Karras","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/jpet.102.040329","article-title":"Antisense oligonucleotide blockade of tumor necrosis factor\u03b1 in two murine models of colitis","volume":"304","author":"Myers","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.imbio.2011.12.002","article-title":"Effect of IL-10 antisense gene therapy in severely burned mice intradermally infected with MRSA","volume":"217","author":"Asai","year":"2012","journal-title":"Immunobiology."},{"key":"10.1016\/j.addr.2021.05.019_b0150","first-page":"35","article-title":"Antisense interleukin-5 reduces eosinophil infiltration and hyperresponsiveness in an allergic asthma model","volume":"27","author":"Huang","year":"2009","journal-title":"Asian Pacific J. Allergy Immunol."},{"key":"10.1016\/j.addr.2021.05.019_b0155","first-page":"279","article-title":"Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans","author":"Napoli","year":"1990","journal-title":"Plant Cell."},{"issue":"6669","key":"10.1016\/j.addr.2021.05.019_b0160","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature."},{"issue":"7228","key":"10.1016\/j.addr.2021.05.019_b0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature07755","article-title":"A three-dimensional view of the molecular machinery of RNA interference","volume":"457","author":"Jinek","year":"2009","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol. Cell."},{"key":"10.1016\/j.addr.2021.05.019_b0175","doi-asserted-by":"crossref","unstructured":"J.-J. Song, S.K. Smith, G.J. Hannon, L. Joshua-Tor, Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity, Science (80-.). 305 (2004) 1434\u20131437. http:\/\/doi.org\/10.1126\/SCIENCE.1102514.","DOI":"10.1126\/science.1102514"},{"key":"10.1016\/j.addr.2021.05.019_b0180","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b0185","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/art.23660","article-title":"Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes","volume":"58","author":"Khoury","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2021.05.019_b0190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2018.05.035","article-title":"Lipid nanoparticles with minimum burst release of TNF-\u03b1 siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate","volume":"283","author":"Aldayel","year":"2018","journal-title":"J. Control. Release."},{"issue":"7242","key":"10.1016\/j.addr.2021.05.019_b0195","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nature07774","article-title":"Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation","volume":"458","author":"Aouadi","year":"2009","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/mt.2008.220","article-title":"Chitosan\/siRNA Nanoparticle\u2013mediated TNF-\u03b1 Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model","volume":"17","author":"Howard","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.05.019_b0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/mt.2013.245","article-title":"TNF-alpha Gene Silencing Using Polymerized siRNAThiolated Glycol Chitosan Nanoparticles for Rheumatoid Arthritis","volume":"22","author":"Lee","year":"2014","journal-title":"Mol. Ther."},{"issue":"1-2","key":"10.1016\/j.addr.2021.05.019_b0210","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2016.10.033","article-title":"Systemic delivery of small interfering RNA targeting nuclear factor \u03baB in mice with collagen-induced arthritis using arginine-histidine-cysteine based oligopeptide-modified polymer nanomicelles","volume":"515","author":"Kanazawa","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.05.019_b0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2017.01.008","article-title":"Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy","volume":"122","author":"Wang","year":"2017","journal-title":"Biomaterials."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0220","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1172\/JCI75673","article-title":"Peptide-siRNA nanocomplexes targeting NF-\u03baB subunit p65 suppress nascent experimental arthritis","volume":"124","author":"Zhou","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2021.05.019_b0225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2015.08.025","article-title":"Notch1 targeting siRNA delivery nanoparticles for rheumatoid arthritis therapy","volume":"216","author":"Kim","year":"2015","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11095-018-2401-x","article-title":"Notch-1 siRNA and Methotrexate towards a Multifunctional Approach in Rhematoid Arthritis Management: a Nanomedicine Approach","volume":"35","author":"Zhao","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2021.05.019_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.intimp.2018.01.010","article-title":"siRNA-mediated c-Rel knockdown ameliorates collagen-induced arthritis in mice","volume":"56","author":"Fan","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0240","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10753-017-0534-4","article-title":"Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice","volume":"40","author":"Luo","year":"2017","journal-title":"Inflammation."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0245","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.imlet.2014.09.018","article-title":"CCR5 small interfering RNA ameliorated joint inflammation in rats with adjuvant-induced arthritis","volume":"162","author":"Duan","year":"2014","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0250","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2217\/nnm.11.90","article-title":"Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model","volume":"6","author":"Scheinman","year":"2011","journal-title":"Nanomedicine."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbrc.2007.03.190","article-title":"siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis","volume":"357","author":"Wada","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2021.05.019_b0260","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/cts.12668","article-title":"siRNA Targeting and Treatment of Gastrointestinal Diseases","volume":"12","author":"Chevalier","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.addr.2021.05.019_b0265","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejpb.2020.08.009","article-title":"Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-\u03b1 siRNA with PAMAM dendrimers in a murine model","volume":"156","author":"Bohr","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b0270","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/acs.biomac.7b00572","article-title":"Anti-Inflammatory Effect of Anti-TNF-\u03b1 SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model","volume":"18","author":"Bohr","year":"2017","journal-title":"Biomacromolecules."},{"issue":"11","key":"10.1016\/j.addr.2021.05.019_b0275","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1021\/mp500473d","article-title":"Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNF\u03b1 gene silencing in macrophages","volume":"11","author":"Kelly","year":"2014","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, Biogenesis, Mechanism, and Function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b0285","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b0290","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microRNA function by antimiR oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar4131","article-title":"MicroRNA control in the development of systemic autoimmunity","volume":"15","author":"Hu","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b0305","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","article-title":"The role of miRNA in inflammation and autoimmunity","volume":"12","author":"Singh","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0310","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","article-title":"microRNA Regulation of Inflammatory Responses","volume":"30","author":"O'Connell","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0315","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1074\/jbc.M110.145870","article-title":"Up-regulation of microRNA-155 in macrophages contributes to increased Tumor Necrosis Factor \u03b1 (TNF\u03b1) production via increased mRNA half-life in alcoholic liver disease","volume":"286","author":"Bala","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2021.05.019_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.01377","article-title":"Anti-inflammatory MicroRNAs and their potential for inflammatory diseases treatment","volume":"9","author":"Tahamtan","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b0325","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.4049\/jimmunol.1900386","article-title":"Monocyte\/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors","volume":"203","author":"Paoletti","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2021.05.019_b0330","doi-asserted-by":"crossref","first-page":"109909","DOI":"10.1016\/j.biopha.2020.109909","article-title":"miR-155 antagomir protect against DSS-induced colitis in mice through regulating Th17\/Treg cell balance by Jarid2\/Wnt\/\u03b2-catenin","volume":"126","author":"Zhu","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0335","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s13311-018-0665-9","article-title":"Inhibition of miR-155 Limits Neuroinflammation and Improves Functional Recovery After Experimental Traumatic Brain Injury in Mice","volume":"16","author":"Henry","year":"2019","journal-title":"Neurotherapeutics."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0340","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0753-x","article-title":"In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response","volume":"13","author":"Pena-Philippides","year":"2016","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.addr.2021.05.019_b0345","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3389\/fphar.2019.00463","article-title":"MiR-155 in the resolution of atherosclerosis","volume":"10","author":"Bruen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2021.05.019_b0350","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1038\/mtna.2016.80","article-title":"Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice","volume":"5","author":"Wang","year":"2016","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.addr.2021.05.019_b0355","first-page":"5567","article-title":"The suppression of miR-181 inhibits inflammatory responses of osteoarthritis through NF-\u03baB signaling pathway","volume":"23","author":"Zhu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.addr.2021.05.019_b0360","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3892\/etm.2017.4708","article-title":"Inhibition of microRNA-34a ameliorates murine collagen-induced arthritis","volume":"14","author":"Dang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2021.05.019_b0365","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b0370","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/bc5004313","article-title":"Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells","volume":"26","author":"Alshaer","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2021.05.019_b0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2017.12.022","article-title":"Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model","volume":"271","author":"Alshaer","year":"2018","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b0380","article-title":"Aptamers Against Pro- and Anti-Inflammatory Cytokines : A Review","author":"Boshtam","year":"2016","journal-title":"Inflammation."},{"key":"10.1016\/j.addr.2021.05.019_b0385","doi-asserted-by":"crossref","first-page":"14230","DOI":"10.1021\/ja036854b","article-title":"RNA Degradation in Cell Extracts: Real-Time Monitoring by Fluorescence Resonance Energy Transfer","volume":"125","author":"Uhler","year":"2003","journal-title":"J. Am. Chem. Soc."},{"issue":"35","key":"10.1016\/j.addr.2021.05.019_b0390","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.1021\/bi060351b","article-title":"In situ analysis of single-stranded and duplex siRNA integrity in living cells","volume":"45","author":"Raemdonck","year":"2006","journal-title":"Biochemistry."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b0395","doi-asserted-by":"crossref","first-page":"e20359","DOI":"10.1371\/journal.pone.0020359","article-title":"SiRNA-like double-stranded RNAs are specifically protected against degradation in human cell extract","volume":"6","author":"Hoerter","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.addr.2021.05.019_b0400","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/nar\/gkg393","article-title":"Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells","volume":"31","author":"Czauderna","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2021.05.019_b0405","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0410","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0006-2952(95)00160-2","article-title":"Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration","volume":"50","author":"Agrawal","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b0415","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","volume":"24","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2021.05.019_b0420","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1093\/nar\/gkaa299","article-title":"Phosphorothioate modified oligonucleotide-protein interactions","volume":"48","author":"Crooke","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b0425","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/cmdc.201000156","article-title":"Off-target effects related to the phosphorothioate modification of nucleic acids","volume":"5","author":"Winkler","year":"2010","journal-title":"ChemMedChem."},{"key":"10.1016\/j.addr.2021.05.019_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7317","article-title":"Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs","volume":"6","author":"Jahns","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.05.019_b0435","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1093\/nar\/gkh936","article-title":"RNA interference using boranophosphate siRNAs: Structure-activity relationships","volume":"32","author":"Hall","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2021.05.019_b0440","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1261\/rna.5103703","article-title":"siRNA function in RNAi: A chemical modification analysis","volume":"9","author":"Chiu","year":"2003","journal-title":"Rna."},{"key":"10.1016\/j.addr.2021.05.019_b0445","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/jm049167j","article-title":"Fully 2 \u2032 -Modified Oligonucleotide Duplexes with Improved in Vitro Unmodified Small Interfering RNA","volume":"48","author":"Allerson","year":"2005","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.addr.2021.05.019_b0450","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1021\/bi0343774","article-title":"RNA interference in mammalian cells by chemically modified RNA","volume":"42","author":"Braasch","year":"2003","journal-title":"Biochemistry."},{"key":"10.1016\/j.addr.2021.05.019_b0455","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1073\/pnas.97.10.5633","article-title":"Potent and nontoxic antisense oligonudeotides containing locked nucleic acids","volume":"97","author":"Wahlestedt","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2021.05.019_b0460","doi-asserted-by":"crossref","first-page":"13233","DOI":"10.1021\/bi0485732","article-title":"LNA (Locked Nucleic Acid):\u00a0 High-Affinity Targeting of Complementary RNA and DNA&#x2020","volume":"43","author":"Vester","year":"2004","journal-title":"Biochemistry."},{"key":"10.1016\/j.addr.2021.05.019_b0465","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U","article-title":"Structural Studies of LNA:RNA Duplexes by NMR: Conformations and Implications for RNase H Activity","volume":"6","author":"Bondensgaard","year":"2000","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.addr.2021.05.019_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/S1074-5521(00)00058-2","article-title":"Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA","volume":"8","author":"Braasch","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.addr.2021.05.019_b0475","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2021.05.019_b0480","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gki193","article-title":"Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality","author":"Elm\u00e9n","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2021.05.019_b0485","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.febslet.2004.11.015","article-title":"Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication","volume":"578","author":"Elm\u00e9n","year":"2004","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0490","first-page":"833","article-title":"Evaluation of locked nucleic acid\u2013modified small interfering RNA in vitro and in vivo","volume":"6","author":"Mook","year":"2007","journal-title":"Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0495","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-2044-2","article-title":"LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration","volume":"21","author":"Luan","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0500","doi-asserted-by":"crossref","first-page":"e0185097","DOI":"10.1371\/journal.pone.0185097","article-title":"Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis","volume":"12","author":"Duijvis","year":"2017","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0505","article-title":"Pharmacological silencing of MicroRNA-152 prevents pressure overload-induced heart failure","volume":"13","author":"LaRocca","year":"2020","journal-title":"Circ. Hear. Fail."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0510","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1432-1033.1995.tb20825.x","article-title":"Antisense Effects of Cholesterol-Oligodeoxynucleotide Conjugates Associated with Poly(alkylcyanoacrylate) Nanoparticles","volume":"232","author":"Godard","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.addr.2021.05.019_b0515","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.omtn.2016.12.011","article-title":"Cholesterol-Containing Nuclease-Resistant siRNA Accumulates in Tumors in a Carrier-free Mode and Silences MDR1 Gene","volume":"6","author":"Chernikov","year":"2017","journal-title":"Mol. Ther. - Nucleic Acids."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b0520","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1021\/jm2000272","article-title":"Synthesis, characterization, and in vivo delivery of siRNA-squalene nanoparticles targeting fusion oncogene in papillary thyroid carcinoma","volume":"54","author":"Raouane","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2021.05.019_b0525","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1093\/nar\/gkz354","article-title":"Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle","volume":"47","author":"Prakash","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2021.05.019_b0530","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2019.03.028","article-title":"The valency of fatty acid conjugates impacts siRNA pharmacokinetics, distribution, and efficacy in vivo","volume":"302","author":"Biscans","year":"2019","journal-title":"J. Control. Release."},{"issue":"49","key":"10.1016\/j.addr.2021.05.019_b0535","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N -acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"9-11","key":"10.1016\/j.addr.2021.05.019_b0540","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1080\/07328319808004687","article-title":"Branched polyethylene glycol (bPEG) conjugated antisense oligonucleotides","volume":"17","author":"Burcovich","year":"1998","journal-title":"Nucleosides and Nucleotides."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0545","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0550","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0165-022X(90)90084-P","article-title":"Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid","volume":"20","author":"Campbell","year":"1990","journal-title":"J. Biochem. Biophys. Methods."},{"key":"10.1016\/j.addr.2021.05.019_b0555","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"14","key":"10.1016\/j.addr.2021.05.019_b0560","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2021.05.019_b0565","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.addr.2020.03.005","article-title":"Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach","volume":"168","author":"Freitag","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0570","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: From concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.05.019_b0575","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b0580","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.05.019_b0585","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1358\/dof.2009.34.9.1413267","article-title":"Advances in systemic siRNA delivery","volume":"34","author":"Leng","year":"2009","journal-title":"Drugs Future."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b0590","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Trang","year":"2011","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0595","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1021\/mp2002076","article-title":"MicroRNA delivery by cationic lipoplexes for lung cancer therapy","volume":"8","author":"Wu","year":"2011","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0600","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.addr.2021.05.019_b0605","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1021\/bi048950a","article-title":"Lipidic Carriers of siRNA: Differences in the Formulation, Cellular Uptake, and Delivery with Plasmid DNA","volume":"43","author":"Spagnou","year":"2004","journal-title":"Biochemistry."},{"issue":"41","key":"10.1016\/j.addr.2021.05.019_b0610","doi-asserted-by":"crossref","first-page":"11186","DOI":"10.1021\/acs.langmuir.5b01979","article-title":"Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor","volume":"31","author":"Nascimento","year":"2015","journal-title":"Langmuir."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0615","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/js9603865","article-title":"Effects of oligodeoxynucleotides on the physicochemical characteristics and cellular uptake of liposomes","volume":"86","author":"Arima","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0620","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2007.11.002","article-title":"Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles","volume":"126","author":"Li","year":"2008","journal-title":"J. Control. Release."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0625","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.0608491104","article-title":"Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1","volume":"104","author":"Peer","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1-2","key":"10.1016\/j.addr.2021.05.019_b0630","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","article-title":"Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: Formation of novel small multilamellar vesicle structures","volume":"1510","author":"Semple","year":"2001","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0635","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.addr.2021.05.019_b0640","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"1-3","key":"10.1016\/j.addr.2021.05.019_b0645","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-3659(97)00246-0","article-title":"Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides","volume":"53","author":"Fattal","year":"1998","journal-title":"J. Control. Release."},{"issue":"9","key":"10.1016\/j.addr.2021.05.019_b0650","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.biopha.2006.07.093","article-title":"Innovative nanotechnologies for the delivery of oligonucleotides and siRNA","volume":"60","author":"Toub","year":"2006","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0655","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nano.2007.03.006","article-title":"Chitosan-coated PLGA nanoparticles for DNA\/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides","volume":"3","author":"Nafee","year":"2007","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0660","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jconrel.2006.02.010","article-title":"Sustained release of nanosized complexes of polyethylenimine and anti-TGF-\u03b22 oligonucleotide improves the outcome of glaucoma surgery","volume":"112","author":"Gomes dos Santos","year":"2006","journal-title":"J. Control. Release."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0665","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jps.10063","article-title":"Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide\/polyethylenimine complexes","volume":"91","author":"De Rosa","year":"2002","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0670","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/bm025684c","article-title":"Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres","volume":"4","author":"De Rosa","year":"2003","journal-title":"Biomacromolecules."},{"issue":"1-2","key":"10.1016\/j.addr.2021.05.019_b0675","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(00)00624-4","article-title":"Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides","volume":"214","author":"Lambert","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.05.019_b0680","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1023\/A:1007582332491","article-title":"Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides","volume":"17","author":"Lambert","year":"2000","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b0685","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s11095-006-9901-9","article-title":"Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma","volume":"23","author":"Toub","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2021.05.019_b0690","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s11095-006-9748-0","article-title":"Oligonucleotide-polyethylenimine complexes targeting retinal cells: structural analysis and application to anti-TGFbeta-2 therapy","volume":"23","author":"Gomes dos Santos","year":"2006","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b0695","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s11095-006-9009-2","article-title":"Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro","volume":"23","author":"Richards Grayson","year":"2006","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0700","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.addr.2009.04.018","article-title":"siRNA delivery systems for cancer treatment","volume":"61","author":"Oh","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.05.019_b0705","first-page":"1102","article-title":"Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer","volume":"6","author":"Boeckle","year":"2004","journal-title":"J. Gene Med. A Cross-disciplinary J. Res. Sci. Gene Transf. Its Clin. Appl."},{"issue":"14","key":"10.1016\/j.addr.2021.05.019_b0710","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.addr.2006.09.008","article-title":"Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity","volume":"58","author":"Hunter","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"23","key":"10.1016\/j.addr.2021.05.019_b0715","doi-asserted-by":"crossref","first-page":"14640","DOI":"10.1073\/pnas.192581499","article-title":"Enhancing polyethylenimine\u2019s delivery of plasmid DNA into mammalian cells","volume":"99","author":"Thomas","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b0720","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/bc025550w","article-title":"Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes","volume":"13","author":"Fischer","year":"2002","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0725","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/ph6020161","article-title":"Dendrimers for siRNA delivery","volume":"6","author":"Biswas","year":"2013","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.addr.2021.05.019_b0730","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pharmaceutics10030126","article-title":"Dendrimers show promise for siRNA and microrna therapeutics","volume":"10","author":"Dzmitruk","year":"2018","journal-title":"Pharmaceutics."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0735","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.3390\/molecules18044451","article-title":"Phosphorus dendrimers as carriers of siRNA\u2014characterisation of dendriplexes","volume":"18","author":"Ferenc","year":"2013","journal-title":"Molecules."},{"key":"10.1016\/j.addr.2021.05.019_b0740","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/0470845821.ch11","article-title":"Characterization of Dendritically Branched Polymers by Small Angle Neutron Scattering (SANS), Small Angle X-Ray Scattering (SAXS) and Transmission Electron Microscopy (TEM)","author":"Bauer","year":"2001","journal-title":"Dendrimers Other Dendritic Polym."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0745","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/B901839P","article-title":"Biomedical applications of dendrimers: a tutorial","volume":"40","author":"Mintzer","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b0750","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1039\/C4CS00261J","article-title":"The dendritic effect illustrated with phosphorus dendrimers","volume":"44","author":"Caminade","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0755","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"issue":"23","key":"10.1016\/j.addr.2021.05.019_b0760","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1039\/C8NR01928B","article-title":"Elucidating the role of surface chemistry on cationic phosphorus dendrimer\u2013siRNA complexation","volume":"10","author":"Deriu","year":"2018","journal-title":"Nanoscale."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b0765","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-selective delivery of macromolecular drugs via the EPR effect: Background and future prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2021.05.019_b0770","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1021\/mp500814f","article-title":"Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)\/alpha-Cyclodextrin Conjugate as an NF-kappa B siRNA Carrier for the Treatment of Fulminant Hepatitis","volume":"12","author":"Motoyama","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.05.019_b0775","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.03.048","article-title":"Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection","volume":"184","author":"Perise-Barrios","year":"2014","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b0780","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/026520499288942","article-title":"Effect of ultrasonication on the stability of oligonucleotides adsorbed on nanoparticles and liposomes","volume":"16","author":"Zobel","year":"1999","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.addr.2021.05.019_b0785","article-title":"Gene silencing by siRNA nanoparticles synthesized via sonochemical method","volume":"5","author":"Shimanovich","year":"2014","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"14","key":"10.1016\/j.addr.2021.05.019_b0790","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1016\/j.biomaterials.2010.01.143","article-title":"Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles","volume":"31","author":"Fay","year":"2010","journal-title":"Biomaterials."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0795","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.gt.3300821","article-title":"Stabilized plasmid-lipid particles: Construction and characterization","volume":"6","author":"Wheeler","year":"1999","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0800","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11095-004-1873-z","article-title":"A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA","volume":"22","author":"Jeffs","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2021.05.019_b0805","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.addr.2021.05.019_b0810","first-page":"305","article-title":"Achieving long-term stability of lipid nanoparticles: Examining the effect of pH, temperature, and lyophilization","volume":"12","author":"Lball","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2021.05.019_b0815","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2019.05.019","article-title":"Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders","volume":"566","author":"Wu","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0820","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/10717544.2020.1790692","article-title":"Functional differences between protamine preparations for the transfection of mRNA","volume":"27","author":"Jarzebska","year":"2020","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0825","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0830","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: The phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today."},{"issue":"6927","key":"10.1016\/j.addr.2021.05.019_b0835","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature01451","article-title":"Regulated portals of entry into the cell","volume":"422","author":"Conner","year":"2003","journal-title":"Nature."},{"key":"10.1016\/j.addr.2021.05.019_b0840","doi-asserted-by":"crossref","unstructured":"B.L. Wolfe, J.A. Trejo, Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis, Traffic. (2007). http:\/\/doi.org\/10.1111\/j.1600-0854.2007.00551.x.","DOI":"10.1111\/j.1600-0854.2007.00551.x"},{"key":"10.1016\/j.addr.2021.05.019_b0845","doi-asserted-by":"crossref","unstructured":"Y. Zwang, Y. Yarden, Systems biology of growth factor-induced receptor endocytosis, Traffic. (2009). http:\/\/doi.org\/10.1111\/j.1600-0854.2008.00870.x.","DOI":"10.1111\/j.1600-0854.2008.00870.x"},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b0850","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(DL-lactide- co glycolide) nanoparticles: implications for drug and gene delivery","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.addr.2021.05.019_b0855","article-title":"Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: Role in PLGA nanoparticle endocytosis","author":"Qaddoumi","year":"2003","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0860","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2006.11.135","article-title":"Targeting of nanoparticles to the clathrin-mediated endocytic pathway","volume":"353","author":"Harush-Frenkel","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0865","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jps.10507","article-title":"Mechanistic Study of the Uptake of Wheat Germ Agglutinin-Conjugated PLGA Nanoparticles by A549 Cells","volume":"93","author":"Mo","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0870","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2009.04.035","article-title":"Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier","volume":"379","author":"Chang","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0875","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0092-8674(01)00472-X","article-title":"Emerging themes in lipid rafts and caveolae","volume":"106","author":"Galbiati","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.addr.2021.05.019_b0880","doi-asserted-by":"crossref","DOI":"10.1124\/pr.54.3.431","article-title":"Caveolae: From cell biology to animal physiology","author":"Razani","year":"2002","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0885","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.biochem.67.1.199","article-title":"The caveolae membrane system","volume":"67","author":"Anderson","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.addr.2021.05.019_b0890","doi-asserted-by":"crossref","unstructured":"L. Pelkmans, A. Helenius, Endocytosis via caveolae, Traffic. (2002). doi:10.1034\/j.1600-0854.2002.30501.x.","DOI":"10.1034\/j.1600-0854.2002.30501.x"},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0895","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.addr.2012.09.041","article-title":"Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances","volume":"65","author":"Xu","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b0900","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1021\/acs.jpcc.5b11059","article-title":"Nanoparticle Multivalency Directed Shifting of Cellular Uptake Mechanism","volume":"120","author":"Dalal","year":"2016","journal-title":"J. Phys. Chem. C."},{"issue":"9","key":"10.1016\/j.addr.2021.05.019_b0905","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1039\/D0CS01127D","article-title":"Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine","volume":"50","author":"Sousa de Almeida","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0910","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-38127-9","article-title":"In-Depth Characterization of Monocyte-Derived Macrophages using a Mass Cytometry-Based Phagocytosis Assay","volume":"9","author":"Schulz","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.addr.2021.05.019_b0915","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2007.06.004","article-title":"Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes","volume":"68","author":"Lingnau","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.addr.2021.05.019_b0920","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00055","article-title":"M2 polarization enhances silica nanoparticle uptake by macrophages","author":"Hoppst\u00e4dter","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b0925","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbamcr.2008.12.022","article-title":"Delivery of endocytosed membrane proteins to the lysosome","volume":"1793","author":"Pryor","year":"2009","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b0930","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00418-008-0384-0","article-title":"Imaging and imagination: Understanding the endo-lysosomal system","volume":"129","author":"Meel","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.addr.2021.05.019_b0935","doi-asserted-by":"crossref","DOI":"10.1023\/A:1022219003551","article-title":"Dynamics of endocytosis and exocytosis of poly(D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells","author":"Panyam","year":"2003","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b0940","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2008.08.018","article-title":"In vivo gene delivery in the mouse lung with lactosylated polyethylenimine, questioning the relevance of in vitro experiments","volume":"132","author":"Grosse","year":"2008","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b0945","doi-asserted-by":"crossref","DOI":"10.1111\/j.1742-4658.2007.05971.x","article-title":"Immunonanoparticles - An effective tool to impair harmful proteolysis in invasive breast tumor cells","author":"Obermajer","year":"2007","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b0950","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc700227z","article-title":"PLGA nanoparticle-peptide conjugate effectively targets intercellular cell-adhesion molecule-1","volume":"19","author":"Zhang","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2021.05.019_b0955","doi-asserted-by":"crossref","unstructured":"I. Mellman, The importance of being acid: the role of acidification in intracellular membrane traffic., J. Exp. Biol. (1992).","DOI":"10.1242\/jeb.172.1.39"},{"key":"10.1016\/j.addr.2021.05.019_b0960","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2002"},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b0965","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b0970","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b0975","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2004.09.003","article-title":"Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic","volume":"118","author":"Pelkmans","year":"2004","journal-title":"Cell."},{"key":"10.1016\/j.addr.2021.05.019_b0980","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.624958","article-title":"Determinants of Phagosomal pH During Host-Pathogen Interactions","author":"Westman","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2021.05.019_b0985","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00188","article-title":"Variations in the phagosomal environment of human neutrophils and mononuclear phagocyte subsets","author":"Foote","year":"2019","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.addr.2021.05.019_b0990","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1091\/mbc.e14-05-0967","article-title":"Contrasting phagosome pH regulation and maturation in human M1 and M2 macrophages","volume":"25","author":"Canton","year":"2014","journal-title":"Mol. Biol. Cell."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b0995","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/molecules24050927","article-title":"Recent advances in cell penetrating peptide-based anticancer therapies","volume":"24","author":"Habault","year":"2019","journal-title":"Molecules."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b1000","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/ijms21072536","article-title":"Nanoparticles modified with cell-penetrating peptides: Conjugation mechanisms, physicochemical properties, and application in cancer diagnosis and therapy","volume":"21","author":"Gessner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b1005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/bip.21367","article-title":"Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: A kinetic study followed by surface plasmon resonance","volume":"94","author":"Henriques","year":"2010","journal-title":"Biopolymers."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b1010","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b1015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/nat.2018.0736","article-title":"GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics","volume":"28","author":"Springer","year":"2018","journal-title":"Nucleic Acid Ther."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b1020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cpt.1974","article-title":"Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine\u2013Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects","volume":"109","author":"Habtemariam","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b1025","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1021\/mp500426r","article-title":"Peptides used in the delivery of small noncoding RNA","volume":"11","author":"Shukla","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.05.019_b1030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.addr.2016.08.004","article-title":"Functional peptides for siRNA delivery","volume":"110-111","author":"Tai","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.05.019_b1035","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jconrel.2020.11.028","article-title":"Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer","volume":"330","author":"Khan","year":"2021","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2019.06.009","article-title":"A study of the endocytosis mechanism and transendothelial activity of lung-targeted GALA-modified liposomes","volume":"307","author":"Santiwarangkool","year":"2019","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biomaterials.2015.01.030","article-title":"Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery","volume":"48","author":"Yang","year":"2015","journal-title":"Biomaterials."},{"key":"10.1016\/j.addr.2021.05.019_b1050","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.5.2953","article-title":"HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes","author":"Weiss","year":"1999","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b1055","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/bc070077d","article-title":"Lung delivery studies using siRNA conjugated to TAT(48\u201360) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity","volume":"18","author":"Moschos","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2021.05.019_b1060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2018.05.034","article-title":"The proton sponge hypothesis: Fable or fact?","volume":"129","author":"Vermeulen","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"43","key":"10.1016\/j.addr.2021.05.019_b1065","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1039\/C8TB00967H","article-title":"The great escape: How cationic polyplexes overcome the endosomal barrier","volume":"6","author":"Bus","year":"2018","journal-title":"J. Mater. Chem. B."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/acsnano.8b05151","article-title":"Super-resolution Imaging of Proton Sponge-Triggered Rupture of Endosomes and Cytosolic Release of Small Interfering RNA","volume":"13","author":"Wojnilowicz","year":"2019","journal-title":"ACS Nano."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b1075","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acsnano.7b07583","article-title":"Endosomal Size and Membrane Leakiness Influence Proton Sponge-Based Rupture of Endosomal Vesicles","volume":"12","author":"Vermeulen","year":"2018","journal-title":"ACS Nano."},{"issue":"50","key":"10.1016\/j.addr.2021.05.019_b1080","doi-asserted-by":"crossref","first-page":"20485","DOI":"10.1073\/pnas.1206811109","article-title":"Size-dependent mechanism of cargo sorting during lysosome-phagosome fusion is controlled by Rab34","volume":"109","author":"Kasmapour","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"18","key":"10.1016\/j.addr.2021.05.019_b1085","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1021\/bi9602019","article-title":"Mechanism of DNA release from cationic liposome\/DNA complexes used in cell transfection","volume":"35","author":"Xu","year":"1996","journal-title":"Biochemistry."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b1090","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/acs.accounts.9b00177","article-title":"Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors","volume":"52","author":"Degors","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b1095","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.addr.2021.05.019_b1100","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.76.7.3348","article-title":"Entrapment of a bacterial plasmid in phospholipid vesicles: Potential for gene transfer","volume":"76","author":"Fraley","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"45","key":"10.1016\/j.addr.2021.05.019_b1105","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b1110","first-page":"233","article-title":"Influence of cationic lipid composition on uptake and intracellular processing of lipid nanoparticle formulations of siRNA, Nanomedicine Nanotechnology","volume":"9","author":"Lin","year":"2013","journal-title":"Biol. Med."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b1115","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/mt.2011.190","article-title":"Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells","volume":"19","author":"Basha","year":"2011","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b1120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b1125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b1130","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/vaccines9010065","article-title":"Nanomaterial delivery systems for mrna vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1140","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60506-4","article-title":"mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification","volume":"10","author":"Moradian","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.05.019_b1145","article-title":"Toll-like receptors and their ligands","author":"Barton","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2021.05.019_b1150","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-6445-1_2","article-title":"Development of the CpG adjuvant 1018: A case study","author":"Campbell","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1189\/jlb.0204089","article-title":"Macrophage activation by a DNA\/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways","volume":"77","author":"Yasuda","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b1160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2567.2006.02451.x","article-title":"DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells","volume":"120","author":"Yoshinaga","year":"2007","journal-title":"Immunology."},{"issue":"10","key":"10.1016\/j.addr.2021.05.019_b1165","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/eji.200635910","article-title":"Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA","volume":"36","author":"Scheel","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2021.05.019_b1170","doi-asserted-by":"crossref","unstructured":"Y. Aramaki, S. Takano, S. Tsuchiya, Induction of apoptosis in macrophages by cationic liposomes, FEBS Lett. (1999). http:\/\/doi.org\/10.1016\/S0014-5793(99)01386-1.","DOI":"10.1016\/S0014-5793(99)01386-1"},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1175","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2608","article-title":"TRPM2 links oxidative stress to NLRP3 inflammasome activation","volume":"4","author":"Zhong","year":"2013","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b1180","first-page":"279","article-title":"Lysine-containing cationic liposomes activate the NLRP3 inflammasome: Effect of a spacer between the head group and the hydrophobic moieties of the lipids, Nanomedicine Nanotechnology","volume":"14","author":"Li","year":"2018","journal-title":"Biol. Med."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b1185","first-page":"775","article-title":"Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways, Nanomedicine Nanotechnology","volume":"10","author":"Lonez","year":"2014","journal-title":"Biol. Med."},{"key":"10.1016\/j.addr.2021.05.019_b1190","doi-asserted-by":"crossref","first-page":"100623","DOI":"10.1016\/j.bbrep.2019.100623","article-title":"Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency","volume":"18","author":"He","year":"2019","journal-title":"Biochem. Biophys. Reports."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b1195","doi-asserted-by":"crossref","first-page":"9648","DOI":"10.1021\/nn203596e","article-title":"Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages","volume":"5","author":"Lunov","year":"2011","journal-title":"ACS Nano."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1200","doi-asserted-by":"crossref","DOI":"10.1111\/imcb.12300","article-title":"Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages","volume":"98","author":"Guo","year":"2020","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2009.12.016","article-title":"Intratracheally instilled mannosylated cationic liposome\/NF\u03baB decoy complexes for effective prevention of LPS-induced lung inflammation","volume":"149","author":"Wijagkanalan","year":"2011","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1210","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.4.2008","article-title":"Specific inhibition of macrophage TNF-\u03b1 expression by in vivo ribozyme treatment","author":"Kisich","year":"1999","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.addr.2021.05.019_b1215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.addr.2021.05.019_b1220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.addr.2017.05.009","article-title":"Applying nanomedicine in maladaptive inflammation and angiogenesis","volume":"119","author":"Alaarg","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.05.019_b1225","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jconrel.2020.07.006","article-title":"Nanoparticle-siRNA: A potential strategy for rheumatoid arthritis therapy?","volume":"325","author":"Feng","year":"2020","journal-title":"J. Control. Release."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b1230","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/art.21876","article-title":"Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor \u03b1 in experimental arthritis","volume":"54","author":"Khoury","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.addr.2021.05.019_b1235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.111.185884","article-title":"Arthritic Joint-Targeting siRNA Encapsulated Liposome: Implication for Treatment Strategy for Rheumatoid Arthritis","volume":"340","author":"Komano","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2021.05.019_b1240","first-page":"2393","article-title":"An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome-protamine-DNA-siRNA complex with cell permeable peptides","volume":"42","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.addr.2021.05.019_b1245","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1021\/acs.molpharmaceut.7b00024","article-title":"Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model","volume":"14","author":"O\u2019Mary","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.05.019_b1250","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpb.2019.06.009","article-title":"Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model","volume":"142","author":"Jansen","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2021.05.019_b1255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12951-018-0382-x","article-title":"Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis","volume":"16","author":"Duan","year":"2018","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b1260","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ymthe.2019.05.002","article-title":"Lipidoid-siRNA Nanoparticle-Mediated IL-1\u03b2 Gene Silencing for Systemic Arthritis Therapy in a Mouse Model","volume":"27","author":"Song","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.05.019_b1265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2018.12.085","article-title":"Lipid- and polymer-based plexes as therapeutic carriers for bioactive molecules","volume":"558","author":"Shende","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"48","key":"10.1016\/j.addr.2021.05.019_b1270","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1039\/C4TB01374C","article-title":"Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo","volume":"2","author":"Yang","year":"2014","journal-title":"J. Mater. Chem. B."},{"key":"10.1016\/j.addr.2021.05.019_b1275","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/IJN.S146942","article-title":"In vivo therapeutic efficacy of TNF\u03b1 silencing by folate-PEG-chitosan-DEAE\/siRNA nanoparticles in arthritic mice","volume":"13","author":"Shi","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2021.05.019_b1280","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fimmu.2016.00305","article-title":"Efficient and non-toxic biological response carrier delivering TNF-\u03b1 shRNA for gene silencing in a murine model of rheumatoid arthritis","volume":"7","author":"Song","year":"2016","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.addr.2021.05.019_b1285","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1039\/C9BM01025D","article-title":"Nanoparticle-delivered siRNA targeting Bruton\u2019s tyrosine kinase for rheumatoid arthritis therapy","volume":"7","author":"Zhao","year":"2019","journal-title":"Biomater. Sci."},{"issue":"11","key":"10.1016\/j.addr.2021.05.019_b1290","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1403012","article-title":"A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA","volume":"194","author":"Mehta","year":"2015","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b1295","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11095-011-0589-0","article-title":"Comparison of Polymeric siRNA Nanocarriers in a Murine LPS-Activated Macrophage Cell Line: Gene Silencing, Toxicity and Off-Target Gene Expression","volume":"29","author":"Jensen","year":"2012","journal-title":"Pharm. Res."},{"issue":"1-2","key":"10.1016\/j.addr.2021.05.019_b1300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2018.08.024","article-title":"Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-\u03b1 siRNA","volume":"550","author":"Pandi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2021.05.019_b1305","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jconrel.2020.11.041","article-title":"RNA interference-mediated suppression of TNF-\u03b1 converting enzyme as an alternative anti-TNF-\u03b1 therapy for rheumatoid arthritis","volume":"330","author":"Song","year":"2021","journal-title":"J. Control. Release."},{"issue":"18","key":"10.1016\/j.addr.2021.05.019_b1310","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.7150\/thno.32268","article-title":"Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy","volume":"9","author":"Hao","year":"2019","journal-title":"Theranostics."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b1315","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3109\/1061186X.2013.765440","article-title":"Enhanced bioavailability of orally administered antisense oligonucleotide to nuclear factor kappa B mRNA after microencapsulation with albumin","volume":"21","author":"Uddin","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2021.05.019_b1320","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1038\/mtna.2014.62","article-title":"Preclinical studies on intestinal administration of antisense oligonucleotides as a model for oral delivery for treatment of duchenne muscular dystrophy","volume":"3","author":"van Putten","year":"2014","journal-title":"Mol. Ther. - Nucleic Acids."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1325","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jps.21084","article-title":"Oral delivery of antisense oligonucleotides in man","volume":"97","author":"Tillman","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b1330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2015.50","article-title":"Therapy: Oral SMAD7 antisense oligonucleotide proves effective for Crohn\u2019s disease","volume":"12","author":"Ray","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b1335","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1407250","article-title":"Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn\u2019s Disease","volume":"372","author":"Monteleone","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.addr.2021.05.019_b1340","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/biomedicines8080234","article-title":"A novel Smad7 genetic variant mapping on the genomic region targeted by mongersen is associated with Crohn\u2019s disease","volume":"8","author":"Di Fusco","year":"2020","journal-title":"Biomedicines."},{"key":"10.1016\/j.addr.2021.05.019_b1345","article-title":"Mongersen (GED-0301) for Active Crohn\u2019s Disease: Results of a Phase 3 Study","volume":"115","author":"Sands","year":"2020","journal-title":"Off. J. Am. Coll. Gastroenterol. | ACG."},{"key":"10.1016\/j.addr.2021.05.019_b1350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.50.2.206","article-title":"Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn\u2019s disease","volume":"50","author":"Ten Hove","year":"2002","journal-title":"Gut."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b1355","doi-asserted-by":"crossref","first-page":"1801389","DOI":"10.1002\/adhm.201801389","article-title":"Orally Delivered Antisense Oligodeoxyribonucleotides of TNF-\u03b1 via Polysaccharide-Based Nanocomposites Targeting Intestinal Inflammation","volume":"8","author":"Duan","year":"2019","journal-title":"Adv. Healthc. Mater."},{"issue":"11","key":"10.1016\/j.addr.2021.05.019_b1360","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","article-title":"Orally delivered thioketal nanoparticles loaded with TNF-\u03b1-siRNA target inflammation and inhibit gene expression in the intestines","volume":"9","author":"Wilson","year":"2010","journal-title":"Nat. Mater."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b1365","doi-asserted-by":"crossref","first-page":"e51830","DOI":"10.1371\/journal.pone.0051830","article-title":"CD98 Positive Eosinophils Contribute to T Helper 1 Pattern Inflammation","volume":"7","author":"Xue","year":"2012","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1370","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/mt.2013.214","article-title":"Targeting intestinal inflammation with CD98 siRNA\/PEI-loaded nanoparticles","volume":"22","author":"Laroui","year":"2014","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.addr.2021.05.019_b1375","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2014.01.056","article-title":"Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice","volume":"146","author":"Xiao","year":"2014","journal-title":"Gastroenterology."},{"issue":"12","key":"10.1016\/j.addr.2021.05.019_b1380","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: Orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics."},{"issue":"30","key":"10.1016\/j.addr.2021.05.019_b1385","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1016\/j.biomaterials.2013.06.008","article-title":"Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-\u03b1 RNA interference for IBD therapy","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials."},{"key":"10.1016\/j.addr.2021.05.019_b1390","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNF\u03b1 gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1395","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2011.1","article-title":"Dual TNF-\u03b1\/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease","volume":"2","author":"Kriegel","year":"2011","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1400","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2013.03.004","article-title":"Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system","volume":"168","author":"McCarthy","year":"2013","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1405","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2015.12.021","article-title":"Colonic gene silencing using siRNA-loaded calcium phosphate\/PLGA nanoparticles ameliorates intestinal inflammation in vivo","volume":"222","author":"Frede","year":"2016","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1410","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1023\/A:1015048419558","article-title":"Distribution of a 20-Mer phosphorothioate oligonucleotide, CGP69846A (ISIS 5132), into airway leukocytes and epithelial cells following intratracheal delivery to Brown-Norway rats","volume":"16","author":"Danahay","year":"1999","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.addr.2021.05.019_b1415","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80240-8","article-title":"The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells","volume":"89","author":"Zheng","year":"1997","journal-title":"Cell."},{"key":"10.1016\/j.addr.2021.05.019_b1420","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.193.11.1247","article-title":"Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression","volume":"193","author":"Finotto","year":"2001","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1425","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-10-39","article-title":"A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice","volume":"10","author":"Fortin","year":"2009","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.addr.2021.05.019_b1430","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jgm.848","article-title":"Polyethylenimine-based antisense oligodeoxynucleotides of IL-4 suppress the production of IL-4 in a murine model of airway inflammation","volume":"8","author":"Seong","year":"2006","journal-title":"J. Gene Med."},{"issue":"30","key":"10.1016\/j.addr.2021.05.019_b1435","doi-asserted-by":"crossref","first-page":"7453","DOI":"10.1016\/j.biomaterials.2013.05.082","article-title":"Dexamethasone-conjugated polyethylenimine\/MIF siRNA complex regulation of particulate matter-induced airway inflammation","volume":"34","author":"Choi","year":"2013","journal-title":"Biomaterials."},{"key":"10.1016\/j.addr.2021.05.019_b1440","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/nano10071248","article-title":"In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8\/CxCL-1 siRNA Delivery to the Lungs","volume":"10","author":"Hibbitts","year":"2020","journal-title":"Nanomaterials."},{"key":"10.1016\/j.addr.2021.05.019_b1445","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.03.029","article-title":"Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma","volume":"229","author":"Xie","year":"2016","journal-title":"J. Control. Release."},{"key":"10.1016\/j.addr.2021.05.019_b1450","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1634","article-title":"T-cell targeted pulmonary <scp>siRNA<\/scp> delivery for the treatment of asthma","volume":"12","author":"Keil","year":"2020","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.addr.2021.05.019_b1455","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56455-2","article-title":"Effective lung-targeted RNAi in mice with peptide-based delivery of nucleic acid","volume":"9","author":"Kurrikoff","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.05.019_b1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20449-w","article-title":"Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation","volume":"12","author":"Bobba","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.05.019_b1465","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjx002.110","article-title":"DOP073 Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease","volume":"11","author":"Atreya","year":"2017","journal-title":"J. Crohn\u2019s Colitis."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21001836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21001836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:08:53Z","timestamp":1759208933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21001836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":293,"alternative-id":["S0169409X21001836"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.05.019","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113809"}}